NEW ORLEANS - A CAR-T-cell therapy known as axicabtagene ciloleucel (axi-cel) is safe and shows encouraging signs of efficacy in a small pilot trial involving patients with lymphoma of the brain ...
In our experience, patients' histories often note a neurologic prodrome years before PCNSL. These lingering illnesses, suggestive of multiple sclerosis or vitritis, might reflect polyclonal lymphoid ...
Patients with primary central nervous system lymphoma aged 70 and older may be eligible for Imbruvica as maintenance treatment. Using Imbruvica (ibrutinib) as maintenance treatment may provide a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback